News
(MENAFN- GetNews) The Key Congenital Adrenal Hyperplasia Companies in the market include - Neurocrine Biosciences, Spruce Biosciences, Neurocrine Bioscience, BridgeBio Pharma, Crinetics ...
The Key Congenital Adrenal Hyperplasia Companies in the market include - Neurocrine Biosciences, Spruce Biosciences, Neurocrine Bioscience, BridgeBio Pharma, Crinetics Pharmaceuticals Inc., Spruce ...
Classic congenital adrenal hyperplasia, more commonly called classic CAH, is when there is an enzyme missing in the adrenal gland, which causes the body to have the inability to make enough cortisol.
The Union Government is committed to eradicating Sickle Cell Anaemia by the year 2047, Union Minister of Tribal Affairs, Jual ...
AIIMS Bhubaneswar is set to be designated as a Centre of Excellence (CoE) for the management and research of Sickle ...
A new study in Nature shows that when pregnant mice don’t have enough iron, their (usually male) fetuses with a Y sex ...
Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...
Bhubaneswar: AIIMS Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for the management and research ...
AIIMS Bhubaneswar treats more than 700 registered Sickle Cell Patients, more than 500 patients are in the age group of 0-19- Union Minister participates in a review meeting and scientific ...
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...
Lewis is a proven global healthcare leader with a track record of utilizing technology to drive both cultural and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results